Ex parte BARBER et al. - Page 8




          Appeal No. 1998-1226                                                        
          Application No. 08/420,330                                                  


          that “Tennent makes no mention whatsoever of the amount of                  
          fibrils” useful in elastomer composites (Brief, page 11).                   
          This argument is not well taken since, as also discussed                    
          above, Tennent does teach amounts of the fibrils, although not              
          numerical amounts (see col. 8, ll. 1-14).                                   
               For the foregoing reasons, we determine that the examiner              
          has presented a prima facie case of obviousness in view of the              
          reference evidence.  Appellants state that they have provided               
          evidence of “surprising and unobvious results” (Brief, page                 
          21).  However, appellants have not explained why these results              
          involve comparisons with the closest prior art, why they are                
          commensurate in scope with the claimed subject matter, and why              
          these results would have been truly unexpected.  Appellants                 
          rely on the evidence on pages 5-6 of the specification but no               
          specific comparisons or results have been disclosed.  Based on              
          the totality of the record, giving due consideration to                     
          appellants’ arguments and evidence, we determine that the                   
          preponderance of evidence weighs most heavily in favor of                   
          obviousness.  Accordingly, the examiner’s rejection of claims               
          49 through 57 under 35 U.S.C. § 103 as unpatentable over                    
          Tennent in view of Geus and Tomoda is affirmed.                             
                                          8                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007